Global Longlife Hospital & Research Complete Financial Statements
GLHRL • Review detailed financials to uncover trends, confirm thesis & journal trades
7 Years of Data
2025 - 2019
Complete Financial Data Export
Export complete financial statements for Global Longlife Hospital & Research (GLHRL).
Downloads include all available records across all periods.
For market performance, see the
GLHRL stock price today
.
Profitability Ratios
EBITDA Margin
16.67%
2025 data
Operating Margin
-720.00%
2025 data
Balance Sheet Ratios
Debt to Equity
1.00
2025 data
Equity Ratio
100.00%
2025 data
Asset Turnover
0.22
2025 data
Year-over-Year Growth Analysis
Comparing March 2025 vs Period
Revenue Growth
+300.0%
Year-over-Year
EBITDA Growth
+300.0%
Year-over-Year
Expense Growth
+280.0%
Year-over-Year
Assets Growth
-35.7%
Year-over-Year
Equity Growth
+3.8%
Year-over-Year
Liabilities Growth
-35.7%
Year-over-Year
Operating Cash Flow Growth
+340.0%
Year-over-Year
Investing Cash Flow Growth
+2300.0%
Year-over-Year
Financing Cash Flow Growth
-533.3%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 24 | 6 | 14 | 24 | 33 | 33 | 34 | 35 |
| Expenses | 19 | 5 | 14 | 20 | 25 | 27 | 30 | 28 |
| EBITDA | 4 | 1 | 0 | 4 | 8 | 6 | 4 | 7 |
| Operating Profit Margin % | 9.00% | -720.00% | -2.00% | 17.00% | 24.00% | 17.00% | 10.00% | 20.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
| Interest | 0 | 0 | 1 | 0 | 1 | 2 | 2 | 2 |
| Profit Before Tax | 3 | 0 | -2 | 3 | 6 | 2 | -1 | 3 |
| Tax | 1 | 0 | 0 | 1 | 2 | 0 | 0 | 1 |
| Net Profit | 2 | 0 | -2 | 2 | 4 | 2 | -1 | 1 |
| Earnings Per Share (₹) | 1.80 | 0.19 | -2.08 | 1.79 | 5.11 | 2.92 | -1.23 | 1.95 |
Related Pages for Global Longlife Hospital & Research
Additional stock information and data for GLHRL
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Total Assets | 27 | 42 | 76 | 34 | 37 | 42 | 43 |
| Current Assets | 23 | 4 | 34 | 11 | 12 | 16 | 15 |
| Fixed Assets | 0 | 17 | 17 | 17 | 18 | 19 | 20 |
| Capital Work in Progress | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 27 | 25 | 58 | 17 | 19 | 23 | 23 |
| LIABILITIES | |||||||
| Total Liabilities | 27 | 42 | 76 | 34 | 37 | 42 | 43 |
| Current Liabilities | 0 | 4 | 4 | 3 | 13 | 17 | 18 |
| Non-Current Liabilities | |||||||
| SHAREHOLDERS' EQUITY | |||||||
| Total Equity | 27 | 26 | 64 | 17 | 14 | 12 | 12 |
| Share Capital | 11 | 11 | 11 | 7 | 7 | 7 | 7 |
| Reserves & Surplus | 16 | 15 | 54 | 10 | 7 | 5 | 5 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | 12 | -5 | -40 | 9 | 7 | 4 | 5 |
| Investing Activities | 22 | -1 | -2 | 0 | 0 | 0 | 0 |
| Financing Activities | -13 | 3 | 46 | -10 | -7 | -3 | -5 |
| Net Cash Flow | 21 | -3 | 3 | 0 | 0 | 1 | 0 |